Cronos Group (Cronos Group) Float Percentage Of Total Shares Outstanding : 52.39% (As of May. 18, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Cronos Group Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Cronos Group's float shares is 200.14 Mil. Cronos Group's total shares outstanding is 382.01 Mil. Cronos Group's float percentage of total shares outstanding is 52.39%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Cronos Group's Insider Ownership is 5.27%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Cronos Group's Institutional Ownership is 7.79%.

Cronos Group Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Cronos Group's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding	=	Float Shares	/	Total Shares Outstanding
	=	200.14	/	382.01
	=	52.39%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cronos Group (Cronos Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cronos Group Inc (NAS:CRON) » Definitions » Float Percentage Of Total Shares Outstanding

Comparable Companies

Traded in Other Exchanges

7CI:Germany CRON:Canada

Address

111 Peter Street, Suite 300, Toronto, ON, CAN, M5V 2H1

Website

https://www.thecronosgroup.com

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S. the company has an option to acquire 10.5% of U.S. multistate operator PharmaCann upon easing of federal prohibition.

Executives

Kamran Khan	director	111 PETER STREET, SUITE 300, TORONTO A6 M5V 2H1
Elizabeth Seegar	director	111 PETER STREET, SUITE 300, TORONTO A6 M5V 2H1
Dominik Meier	director	111 PETER STREET, SUITE 300, TORONTO A6 M5V 2H1
Jason Marc Adler	director	111 PETER STREET, SUITE 300, TORONTO A6 M5V 2G9
Mcginness James Andrew Iii	officer: VP, Controller	C/O MARKETWISE, 1125 N. CHARLES STREET, BALTIMORE MD 21201
Maple Holdco (bermuda) Ltd.	10 percent owner	C/O ALTRIA GROUP, INC., 6601 WEST BROAD STREET, RICHMOND VA 23230
Maple Acquireco (canada) Ulc	10 percent owner	C/O ALTRIA GROUP, INC., 6601 WEST BROAD STREET, RICHMOND VA 23230
Altria Summit Llc	10 percent owner	C/O ALTRIA GROUP, INC., 6601 WEST BROAD STREET, RICHMOND VA 23230
Altria Group, Inc.	10 percent owner	6601 WEST BROAD STREET, RICHMOND VA 23230
James Holm	officer: Chief Financial Officer	111 PETER STREET, SUITE 300, TORONTO A6 M5V 2H1
Arye Weigensberg	officer: See Remarks	111 PETER STREET, SUITE 300, TORONTO A6 MV5 2H1
Doucet Terrence Gregory Joseph	officer: See Remarks	111 PETER STREET, SUITE 300, TORONTO A6 M5V 2H1
John Griese	officer: See Remarks	111 PETER STREET, SUITE 300, TORONTO A6 M5V 2H1
Ran Gorelik	officer: General Manager (Israel)	111 PETER STREET, SUITE 300, TORONTO A6 M5V 2H1
Robert L Madore	officer: Chief Financial Officer	C/O RALPH LAUREN CORPORATION, 650 MADISON AVENUE, NEW YORK NY 10022